Dendritic cell combination therapy reduces the toxicity of triptolide and ameliorates colitis in murine models

Triptolide (TP) exerts a promising effect in the treatment of ulcerative colitis (UC). However, its toxicity seriously hinders its application in the clinic. Previous studies indicated that dendritic cells (DCs) are the main target through which TP exerts its immunoregulatory effect. Thus, we design...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Quan, Ma, Guang-chao, Wu, Hao, Li, Meng, Xu, Wei, Wang, Guo-jun, Wang, Dong, Zhang, Cong-en, Ma, Zhi-jie, Zhang, Zhong-tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890574/
https://www.ncbi.nlm.nih.gov/pubmed/35225120
http://dx.doi.org/10.1080/10717544.2022.2044935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890574/
https://www.ncbi.nlm.nih.gov/pubmed/35225120
http://dx.doi.org/10.1080/10717544.2022.2044935

Ejemplares similares